Medical Research News and Research

RSS

Merck announces collaboration to create Calibr for early-stage translational research

Merck, known outside the United States and Canada as MSD, today announced a collaboration to create the California Institute for Biomedical Research (Calibr), an independent, not-for-profit organization (501c3) established to accelerate the translation of basic biomedical research into innovative, new medicines to treat disease.

16 Mar 2012

Scale to measure potential harm caused by invasive placebos in local anaesthesia research

A scale developed to measure the potential harm caused by invasive placebos in local anaesthesia research has been successfully tested by a group of 43 independent clinicians, according to research published in the April issue of Anaesthesia.

15 Mar 2012

GenVec 2011 net loss decreases to $7.4 million

Today GenVec, Inc. announced financial results for the fourth quarter and year ended December 31, 2011. For the year ended December 31, 2011, the Company reported a net loss of $7.4 million, or $0.58 per share, compared with a net loss of $12.3 million, or $0.97 per share, for the year ended December 31, 2010.

15 Mar 2012

Study identifies 190 proteins crucial to the functions of key immune sensors

In a healthy immune system, invading pathogens trigger a cascade of alerts and responses to fight off the infection. Sensors called toll-like receptors, or TLRs, act as one of the first lines of defense. Two of these sensors, known as TLR7 and TLR9, specifically recognize and respond to microbial RNA and DNA, respectively. But what determines how these TLRs get where they need to be and sound the alarm for pathogen infection?

15 Mar 2012

Planned elective repeat cesarean lowers risk of serious complications

A major study led by the University of Adelaide has found that women who have had one prior cesarean can lower the risk of death and serious complications for their next baby - and themselves - by electing to have another cesarean.

14 Mar 2012

Antibody-based therapies successfully protect monkeys from deadly Ebola and Marburg viruses

Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.

14 Mar 2012

Homeopathy could soon be declared “baseless and unethical” in Australia

Homeopathy is a branch of alternative medicine based on the principles of “like-cures-like” and “ultra-dilutions”. The first principle says substances that can cause symptoms can be used in diluted form to treat the same symptom in an illness, and the second says the more dilute a substance is, the more potent it is.

14 Mar 2012

Root cause of dental phobia

Women in their forties are more likely to have dental anxiety than any other age group according to a University of Sydney study into dental anxiety and phobia.

11 Mar 2012

Gene that causes aggression in men under stress discovered

Scientists have found that “macho” gene that makes men behave more aggressively than women under stress. They say this one gene could explain why men have a 'fight or flight' response while women are more likely to try and defuse the situation. The study has been published in the journal BioEssays.

11 Mar 2012

Tumors can be more complex than imagined earlier: Study

Researchers speculate that cancers may be more complex that they knew. And that's why a single tissue sample taken from a single tumor may not be the best way to figure out a course of treatment they claim.

11 Mar 2012

Patients with advanced Alzheimer’s benefit from drugs: Study finds

According to new developments patients with advanced Alzheimer’s disease could benefit from drug treatment to slow its progression. Scientists have shown for the first time that drugs used to slow the disease in its early stages also work when the condition is advanced, greatly extending the population who could be treated.

8 Mar 2012

First ever analysis of genetic variation between different regions of same tumour

Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine.

8 Mar 2012

Heroes of Military Medicine award recipients to be honored on May 2, 2012

The Center for Public-Private Partnerships at The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. is pleased to announce the recipients of the 2012 Heroes of Military Medicine awards.

7 Mar 2012

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced Thrombotech Ltd., a portfolio company which Hadasit holds a 24% stake in, received an IND approval from the Food and Drug Administration enabling the initiation of a Phase IIa clinical trial in the U.S.

5 Mar 2012

Scientists discover how to enhance production of hepatocytes to repair damaged liver tissue

Scientists have shed light on how the liver repairs itself with research that could help develop drugs to treat liver disease.

4 Mar 2012

Northern Ireland has higher survival rates for pancreatic cancer, leukaemia

The first audit of leukaemia treatment and survival in Northern Ireland by the Cancer Registry (NICR) at Queen's University Belfast has shown that survival rates for the disease here are at the highest levels since data collection began in 1993.

2 Mar 2012

New system improves chances of pregnancy during IVF

A novel system for processing embryos during IVF treatment has been shown to significantly improve the chances of pregnancy - by more than a quarter.

1 Mar 2012

Tenfold increase in OARnet network bandwidth speeds will boost medical research

Following his State of the State announcement of a tenfold boost to OARnet's statewide network bandwidth, Governor John R. Kasich joined medical researchers from across the state on Feb. 27 in a video teleconference to discuss how the faster network speeds will help enhance innovation.

29 Feb 2012

Cancer survival rates on the rise in Northern Ireland

Despite the rising incidence of cancer in Northern Ireland, the number of people surviving the disease in the country is increasing significantly year on year.

29 Feb 2012

Scientists demonstrate how immortal flatworm overcomes aging process

Researchers from The University of Nottingham have demonstrated how a species of flatworm overcomes the ageing process to be potentially immortal.

28 Feb 2012

Medical Research News and Research

Merck announces collaboration to create Calibr for early-stage translational research

Scale to measure potential harm caused by invasive placebos in local anaesthesia research

GenVec 2011 net loss decreases to $7.4 million

Study identifies 190 proteins crucial to the functions of key immune sensors

Planned elective repeat cesarean lowers risk of serious complications

Antibody-based therapies successfully protect monkeys from deadly Ebola and Marburg viruses

Homeopathy could soon be declared “baseless and unethical” in Australia

Root cause of dental phobia

Gene that causes aggression in men under stress discovered

Tumors can be more complex than imagined earlier: Study

Patients with advanced Alzheimer’s benefit from drugs: Study finds

First ever analysis of genetic variation between different regions of same tumour

Heroes of Military Medicine award recipients to be honored on May 2, 2012

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Scientists discover how to enhance production of hepatocytes to repair damaged liver tissue

Northern Ireland has higher survival rates for pancreatic cancer, leukaemia

New system improves chances of pregnancy during IVF

Tenfold increase in OARnet network bandwidth speeds will boost medical research

Cancer survival rates on the rise in Northern Ireland

Scientists demonstrate how immortal flatworm overcomes aging process

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News